2 growth stocks that could surge under the Donald Trump presidency

The new US President says he’ll take the US economy to new heights, and there are plenty of companies that could prosper. Dr James Fox highlights two.

| More on:
The flag of the United States of America flying in front of the Capitol building

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Growth stocks can take our portfolios to the next level, just like Donald Trump wants to send the US economy into overdrive. But which companies might benefit from the returning President? Well, proposed tax cuts should benefit most US enterprises in some ways, while tariffs will help some firms up to a point. However, here are two companies with very specific reasons to benefit.

SpaceX’s competition

SpaceX may have made a lot of headline in recent months given Elon Musk’s alliance with Trump, with the company likely to gain from the new US government’s space ambitions. However, Rocket Lab (NASDAQ:RKLB) is a listed and much cheaper alternative to SpaceX and should also benefit from increased activity in the space realm.

Rocket Lab might not be Mars-ready, but it has some distinct advantages over SpaceX. This includes cost-effectiveness for dedicated launches in payload class up to 13 tons with its upcoming Neutron ‘launch vehicle’. Its dedicated launch capabilities and reputation for precise orbital insertions also suggest it doesn’t deserve the massive discount to SpaceX (that unlisted company recently bought shares back from employees suggesting a value of $350bn compared to Rocket Lab’s $13.7bn).

As trading opened on Tuesday (21 January), Rocket Lab stock surged 30%. This followed Trump’s most recent remarks about prioritising space exploration at his inauguration. This is actually rather gutting for me as I touted the stock on Friday, noting its $1.8trn addressable market by 2035, but wasn’t able to purchase the stock before the market opened on Tuesday.

Are there any risks? Well, some are related to SpaceX. While there’s probably room for multiple players in this sector, there’s the risk that SpaceX, given its likely strong balance sheet, fast-paced innovation, and links to Trump, could hoover up a large proportion of government contracts. I’m not convinced by this argument, but time will tell.

Obviously, I wish I’d bought this stock last week. But I could also say that for other companies in my watchlist, including Opfi and Innovative Solutions and Support. At this higher price, I’ll have to re-evaluate my interest in Rocket Lab.

AI offers efficiencies

I’m not particularly bullish on Palantir Technologies (NASDAQ:PLTR) but I know a lot of people think this software company will go far. That’s because this firm, which embeds AI into its platforms to assist with data integration, decision-making, and operations at scale, was founded by Peter Thiel — a Trump backer and co-founder of PayPal (with which Elon Musk was also involved).

However, it would be wrong of me to suggest Thiel’s closeness to Trump is the only reason this business could succeed. The company has a long track record of working with US defence and intelligence agencies and its Starlab consortium for a commercial space station aligns with Trump’s ambition in space. Moreover, its platforms also deliver the all-important efficiency that could help reduce government bloat.

The risks of investing in Palantir lie in the valuation. It’s extraordinarily expensive At 173 times forward earnings — very similar to Musk’s Tesla valuation. While the expected growth rate is very strong, the price-to-earnings-to-growth (PEG) ratio stands around seven times. As such, I don’t expect to add this stock to my portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Fox has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 UK shares that could soar if interest rates sprint lower!

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

My favourite FTSE dividend stock just jumped 17%! So why am I sad?

This investor has mixed feelings today as a quality dividend stock from the FTSE 250 surged higher in his portfolio.…

Read more »

Investing Articles

Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

Read more »

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »

Investing Articles

Is this my chance to buy Alphabet shares?

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy…

Read more »

Senior woman potting plant in garden at home
Investing Articles

£10k in savings? Here’s how an investor could aim for a monthly second income of £1,200

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio…

Read more »